Mosaic ImmunoEngineering, Inc. (CPMV)
- Previous Close
0.4000 - Open
0.1031 - Bid --
- Ask --
- Day's Range
0.1031 - 0.4000 - 52 Week Range
0.1020 - 1.0000 - Volume
1,000 - Avg. Volume
550 - Market Cap (intraday)
2.897M - Beta (5Y Monthly) -1.80
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1400 - Earnings Date Aug 3, 2024 - Aug 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 2, 2007
- 1y Target Est
--
Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate is MIE-101 which is based on cowpea mosaic virus which is non-infectious in humans and animals. The company was founded in 2020 and is based in Novato, California.
www.mosaicie.comRecent News: CPMV
Performance Overview: CPMV
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CPMV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CPMV
Valuation Measures
Market Cap
2.90M
Enterprise Value
4.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-396.93%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.01M
Diluted EPS (ttm)
-0.1400
Balance Sheet and Cash Flow
Total Cash (mrq)
156.18k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-66.09k
Research Analysis: CPMV
Company Insights: CPMV
CPMV does not have Company Insights